IMA
ImageneBio, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$62.71M
P/E Ratio
—
EPS
$-4.78
Beta
—
52W High
$18.00
52W Low
$3.94
50-Day MA
$5.57
200-Day MA
$7.52
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About ImageneBio, Inc.
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-54.04M |
| Operating Margin | 0.00% |
| Return on Equity | -86.20% |
| Return on Assets | -45.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $11.91 |
| Price-to-Book | 0.51 |
| Price-to-Sales (TTM) | 83.32 |
| EV/Revenue | 31.86 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $11.28M |
| Float | $5.80M |
| % Insiders | 14.96% |
| % Institutions | 55.48% |
Historical Volatility
HV 10-Day
59.36%
HV 20-Day
66.89%
HV 30-Day
86.15%
HV 60-Day
71.81%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($24.00 target)
2
Buy1
SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026